(3-methyl-1-(2-(1-methyl-1H-indol-5-ylamino)pyrimidin-4-yl)-1H-pyrazol-4-yl)methanol → 3-methyl-1-(2-(1-methyl-1H-indol-5-ylamino)pyrimidin-4-yl)-1H-pyrazole-4-carbaldehyde
반응식
[CH3:1][C:2]1[C:6]([CH2:7][OH:8])=[CH:5][N:4]([C:9]2[CH:14]=[CH:13][N:12]=[C:11]([NH:15][C:16]3[CH:17]=[C:18]4[C:22](=[CH:23][CH:24]=3)[N:21]([CH3:25])[CH:20]=[CH:19]4)[N:10]=2)[N:3]=1>ClCCl.O=[Mn]=O>[CH3:1][C:2]1[C:6]([CH:7]=[O:8])=[CH:5][N:4]([C:9]2[CH:14]=[CH:13][N:12]=[C:11]([NH:15][C:16]3[CH:17]=[C:18]4[C:22](=[CH:23][CH:24]=3)[N:21]([CH3:25])[CH:20]=[CH:19]4)[N:10]=2)[N:3]=1참가 물질
4
실험 절차
To a solution of intermediate 7 (214 mg, 0.64 mmol) in 100 mL of dichloromethane (DCM), was added 58% of activated MnO2 (0.58 g, 6 equiv.). After being stirred for 12 hours at room temperature, the reaction mixture was passed through a pad of Celite and rinsed with dichloromethane. The filtrate was concentrated in vacuo to give desired intermediate 8 as a pale yellow solid (0.77 g, 36%); MS (ESI) m/z 333 [M+H]+
후처리
- washrinsed with dichloromethane
- concentrationThe filtrate was concentrated in vacuo
출처 및 근거
- ORD 기록
- ord-f845c53f259549b9b71ca9dd730c8199
- 출처 데이터셋
- uspto-grants-2014_10
- 특허 번호
- US08871778B2
반응 노트
불러오는 중…